Ivan V. Litvinov MD, PhD
Anie Philip, PhD
Stéphane Roy PhD
Welcome to the 6th Annual meeting of the Skin Research Group of Canada (SRGC). The SRGС Scientific Organizing Committee is delighted to invite you to the 2019 Annual Meeting in Calgary. This year will be our 2nd joint meeting with the Canadian Dermatology Association (CDA), a collaboration that will undoubtedly help bring Canadian basic science, translational and clinical skin research expertise under one roof. The 2019 SRGC program will showcase recent advances in skin research, and facilitate collaborations and knowledge translation. The meeting will help build critical connections between scientists, clinicians, patient alliance/patient advocacy groups, and industry partners to answer important questions to improve diagnosis and management of skin diseases. Our joint meeting will be equally beneficial to clinicians, basic scientists and industry partners engaged in skin research and will bolster our efforts to understand the pathophysiological mechanisms underlying skin diseases such as psoriasis, eczema, skin cancer, autoimmune diseases, wound healing, skin regeneration and many other topics. At least 25 % of the conference time is dedicated to interactive sessions.
• Participants will get acquainted with molecular pathogenesis of a number of skin diseases including psoriasis, atopic dermatitis, acne, vitiligo, scleroderma, epidermolysis bullosa, cutaneous lymphomas, melanoma, non-melanoma skin cancers and chronic wound healing.
• Participants will be able to learn of recent advances in research on these diseases and will gain knowledge on how targeted therapies can be used to treat these conditions.
• Participant will also be able to critically evaluate how future research on these conditions can improve their diagnosis and management.
We need your participation to make this meeting a success!
Annual Conference Scientific Organizing Committee,
Dr. Youwen Zhou
University of British Columbia
June 26, 2019
SRGC STATE-OF-THE-ART LECTURE
“Therapeutic Targeting of Pathogenic Drivers of Cutaneous T Cell Lymphoma”